Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Sinopharm Group Pharma 50

Sinopharm (pharmaceutical distribution segment)

Rank: 2

2021 Rank: 1

Shanghai, China
http://ir.sinopharmgroup.com.cn

2021 Revenues ($USD) : $60,450,609,227
2021 Revenues (foreign currencies) : RMB389,954,790,000
2021 R&D spend : na
2021 Number of Employees : na
Fiscal Year End : 12/31/2021
Leader : President Liu Yong

The Chinese state-owned pharmaceutical giant Sinopharm was founded in 2003. Six years later, its stock was listed on the Hong Kong stock exchange (stock code: 01099. HK). The company continues to ascend in Fortune’s Global 500 ranking. In 2013, the publication put Sinopharm in slot 446. In 2021, it pegged the company at slot 109. In addition to focusing on drug development, the company also operates a substantial China-based logistics network for drugs and medical devices. —BB

Sinopharm

[A nurse holds a vial of Sinopharm's COVID-19 vaccine. Image courtesy of Wikimedia Commons.]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE